Stay updated on Efficacy of Nintedanib + Sildenafil in IPF Clinical Trial
Sign up to get notified when there's something new on the Efficacy of Nintedanib + Sildenafil in IPF Clinical Trial page.

Latest updates to the Efficacy of Nintedanib + Sildenafil in IPF Clinical Trial page
- CheckyesterdayNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedRevision: v3.4.2 has been added; the prior 'Notice Because of a lapse in government funding...' message (v3.4.1) has been removed.SummaryDifference0.2%

- Check23 days agoChange DetectedAdded a government funding/status notice about potential delays and the NIH Clinical Center’s operations. The release version was updated to Revision: v3.4.1, replacing v3.4.0.SummaryDifference0.2%

- Check30 days agoChange DetectedShow glossary feature added and page revision updated to v3.4.0, introducing a 'Last Update Submitted that Met QC Criteria' label and a 'No FEAR Act Data' notice; the previous 'Last Update Submitted that met QC Criteria' and 'No FEAR Act data' entries were removed.SummaryDifference0.1%

- Check44 days agoChange DetectedRevision updated to v3.3.4, replacing v3.3.3, with no changes to core study content; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check66 days agoChange DetectedNew study sites have been added across the US, Australia, and Canada, and some existing location sections have been removed. Page revision updated to v3.3.3.SummaryDifference1%

- Check88 days agoChange DetectedRevision: v3.3.2 was deployed; the changes appear to be a software/UI update with no changes to study content or eligibility. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Efficacy of Nintedanib + Sildenafil in IPF Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efficacy of Nintedanib + Sildenafil in IPF Clinical Trial page.